Altered Expression Pattern of Topoisomerase IIα, in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1987 • 64,270 citations

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

1987 • 45,673 citations

Cellular roles of DNA topoisomerases: a molecular perspective

2002 • 2,232 citations

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

1987 • 1,906 citations

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium

2000 • 1,445 citations

The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis

1999 • 916 citations

Real-time quantitative RT–PCR after laser-assisted cell picking

1998 • 578 citations

Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

2000 • 537 citations

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme

1998 • 498 citations

Topoisomerase II: A specific marker for cell proliferation.

1986 • 434 citations

Know thy neighbor: stromal cells can contribute oncogenic signals

2001 • 422 citations

Cancer and aging: a model for the cancer promoting effects of the aging stroma

2002 • 291 citations

Laser capture microdissection in pathology

2000 • 273 citations

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.

1989 • 250 citations

Tumorigenic conversion of immortal human keratinocytes through stromal cell activation

1998 • 236 citations

Stromal Involvement In Malignant Growth

1988 • 225 citations

Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

2004 • 213 citations

Carcinoma of the ovary.

2001 • 198 citations

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

1991 • 120 citations

Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.

1999 • 107 citations

Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.

1982 • 105 citations

Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death

1998 • 103 citations

p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene

1996 • 91 citations

HER‐2 and TOP2A coamplification in urinary bladder cancer

2003 • 89 citations

Structural organization of the human TOP2A and TOP2B genes

1998 • 65 citations

The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: A fluorescence in situ hybridization study

2005 • 61 citations

Operative Results after Primary and Secondary Debulking‐Operations in Advanced Ovarian Cancer (AOC)

1998 • 60 citations

Coamplified and overexpressed genes at ERBB2 locus in gastric cancer

2004 • 58 citations

Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation.

2001 • 57 citations

Laser Capture Microdissection: Methodical Aspects and Applications with Emphasis on Immuno-Laser Capture Microdissection

2000 • 48 citations

Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma

2004 • 47 citations

Clinical resistance to topoisomerase-targeted drugs

1998 • 47 citations

Topoisomerase II as a target of anticancer drug action in mammalian cells.

1987 • 43 citations

Detection of Human Topoisomerase IIα in Cell Lines and Tissues: Characterization of Five Novel Monoclonal Antibodies

1997 • 35 citations

Gene copy mapping of the ERBB2/TOP2A region in breast cancer

2004 • 33 citations

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts

2000 • 28 citations

A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.

2002 • 26 citations

Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.

2001 • 26 citations

Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.

1997 • 25 citations

Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2

2005 • 23 citations

The role of anthracyclines in epithelial ovarian cancer

1999 • 23 citations

Second-line treatment and consolidation therapies in advanced ovarian cancer

2001 • 22 citations

Gene expression of DNA topoisomerases I, IIα and IIβ and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1996 • 20 citations

The role of molecular biology in understanding ovarian cancer initiation and progression

2001 • 16 citations

Untitled

1999 • 13 citations

Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

2003 • 11 citations

Die Expression von c-erbB-2 und Topoisomerase IIα in Relation zur Zytostatikaresistenz beim Ovarialkarzinom

2002 • 3 citations

Randomized Phase III trial: Topotecan vs. topotecan/etoposide vs topotecan/gemcitabine as second-line treatment for patients with relapsed ovarian cancer

2004 • 3 citations

Randomized Phase III trial: Topotecan vs. topotecan/etoposide vs topotecan/gemcitabine as second-line treatment for patients with relapsed ovarian cancer

2004 • 2 citations